6-3113257-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PP3_ModeratePP5BS1_Supporting
The NM_001354930.2(RIPK1):c.1934C>T(p.Thr645Met) variant causes a missense change. The variant allele was found at a frequency of 0.000117 in 1,614,098 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T645T) has been classified as Likely benign.
Frequency
Consequence
NM_001354930.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RIPK1 | NM_001354930.2 | c.1934C>T | p.Thr645Met | missense_variant | Exon 11 of 11 | ENST00000259808.9 | NP_001341859.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152162Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000558 AC: 14AN: 251088Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135736
GnomAD4 exome AF: 0.000118 AC: 172AN: 1461818Hom.: 0 Cov.: 31 AF XY: 0.000118 AC XY: 86AN XY: 727200
GnomAD4 genome AF: 0.000112 AC: 17AN: 152280Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74466
ClinVar
Submissions by phenotype
Immunodeficiency 57 Pathogenic:3
This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. This c.1934C>T (p.T645M) variant has been previously reported in patients from two unrelated families with very early onset inflammatory bowel disease, diarrhea and recurrent infections [PMID 30591564] Functional studies showed that the T645M mutant proteins lead to impaired proinflammatory signaling, increased inflammasome activity and defective cell death response in intestinal epithelial cells [PMID 30591564] -
ACMG classification criteria: PS3 supporting, PM2 supporting, PM3 strong, PP3 supporting -
The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.007%). Functional studies provide moderate evidence of the variant having a damaging effect on the gene or gene product (PMID: 30591564). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.69; 3Cnet: 0.37). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with RIPK1 related disorder (ClinVar ID: VCV000598788 / PMID: 30591564). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. -
Inborn error of immunity;C4749850:IL10-related early-onset inflammatory bowel disease Pathogenic:1
patients suffered from recurrent bacterial and/or viral infections and had episodes of diarrhea and/or colitis -
See cases Pathogenic:1
This missense change has been observed in individual(s) with clinical features of RIPK1 deficiency (PMID: 30591564, 32181283). RIPK1 is an important regulator of inflammation and cell death. RIPK1-mediated necroptosis and neuroinflammation (PMID: 30467385), might contribute to the pathogenesis of Autism Spectrum disorder (ASD) (PMID: 31029798, 23147483). Many children with ASD experience diarhea and irritable bowel movement. In our study, an ASD patient carried this mutation. -
Autoinflammation with episodic fever and lymphadenopathy Pathogenic:1
- -
not provided Uncertain:1
This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 645 of the RIPK1 protein (p.Thr645Met). This variant is present in population databases (rs116040763, gnomAD 0.01%). This missense change has been observed in individual(s) with clinical features of RIPK1 deficiency (PMID: 30591564, 32181283, 36466854, 36939041). ClinVar contains an entry for this variant (Variation ID: 598788). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects RIPK1 function (PMID: 30591564). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at